Suchergebnisse - "Huang, Xin"

PubPharm (85)

21

Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2020

von Drilon, A. | Oxnard, G. | Tan, D. | +42

CommentIn: N Engl J Med. 2020 Aug 27;383(9):868-869. - PMID 32846067

22

Efficacy of Selpercatinib in RET-Altered Thyroid Cancers

enthalten in: The New England journal of medicine | 2020

von Wirth, L. | Sherman, E. | Robinson, B. | +38

CommentIn: N Engl J Med. 2020 Aug 27;383(9):868-869. - PMID 32846067

23

Structural Basis of AZD9291 Selectivity for EGFR T790M

enthalten in: Journal of medicinal chemistry | 2020

von Yan, X. | Ayaz, P. | Zhu, S. | +10

24

Discovery of new thieno[3,2-d]pyrimidine derivatives targeting EGFRL858R/T790M NSCLCs by the conformation constrained strategy

enthalten in: European journal of medicinal chemistry | 2020

von Chen, Y. | Yang, L. | Qiao, H. | +7

25

Breast-conserving surgery without axillary lymph node surgery or radiotherapy is safe for HER2-positive and triple negative breast cancer patients over 70 years of age

enthalten in: Breast cancer research and treatment | 2020

von Zhong, Y. | Xu, Y. | Zhou, Y. | +11

26

Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer : study protocol of a randomized controlled trial

enthalten in: BMC cancer | 2020

von Wang, C. | Lin, Y. | Zhou, Y. | +10

27

Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer in Young Women : Emerging Data in the Era of Molecularly Targeted Agents

enthalten in: The oncologist | 2020

von Shah, A. | Metzger, O. | Bartlett, C. | +3

28

Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer

enthalten in: The breast journal | 2020

von Gelmon, K. | Cristofanilli, M. | Rugo, H. | +11

29

Validation of CTS5 model in large-scale breast cancer population and the impact of menopausal and HER2 status on its prognostic value

enthalten in: Scientific reports | 2020

von Wang, C. | Chen, C. | Lin, Y. | +10

30

Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer

enthalten in: PloS one | 2020

von Huang Bartlett, C. | Mardekian, J. | Cotter, M. | +4